RNA PCR SCREENING FOR HIV COULD HALVE SEROCONVERSION WINDOW TO 11 DAYS, FDA CONFERENCE TOLD; COST/BENEFIT RATIO IS POSSIBLE DRAWBACK TO DEVELOPMENT
This article was originally published in The Gray Sheet
Executive Summary
The use of RNA polymerase chain reaction screening for HIV could allow detection in blood donors 11 days earlier than third- generation anti-HIV-1/HIV-2 enzyme immunosorbent assays (EIAs), Michael Busch, MD, PhD, Irwin Memorial Blood Centers and University of California, San Francisco, told a Sept. 26-28 FDA conference.